aTyr Pharma, Inc. (ATYR)
NASDAQ: ATYR · Real-Time Price · USD
0.900
+0.076 (9.17%)
At close: Mar 9, 2026, 4:00 PM EDT
0.877
-0.023 (-2.52%)
After-hours: Mar 9, 2026, 5:49 PM EDT
aTyr Pharma Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 0.19 | 0.24 | 0.35 | 10.39 | - | |
| Revenue Growth (YoY) | -19.15% | -33.43% | -96.60% | - | - | |
| Cost of Revenue | 60.22 | 54.37 | 42.29 | 42.81 | 23.26 | |
| Gross Profit | -60.03 | -54.14 | -41.94 | -32.42 | -23.26 | |
| Selling, General & Admin | 17.6 | 13.78 | 12.98 | 13.98 | 10.75 | |
| Operating Expenses | 17.6 | 13.78 | 12.98 | 13.98 | 10.75 | |
| Operating Income | -77.63 | -67.91 | -54.92 | -46.4 | -34.02 | |
| Other Non Operating Income (Expenses) | 3.5 | 3.89 | 4.52 | 1.06 | 0.24 | |
| EBT Excluding Unusual Items | -74.12 | -64.02 | -50.4 | -45.34 | -33.78 | |
| Pretax Income | -74.12 | -64.02 | -50.4 | -45.34 | -33.78 | |
| Earnings From Continuing Operations | -74.12 | -64.02 | -50.4 | -45.34 | -33.78 | |
| Minority Interest in Earnings | 0.01 | -0 | 0.01 | 0.01 | 0.01 | |
| Net Income | -74.12 | -64.02 | -50.39 | -45.34 | -33.77 | |
| Net Income to Common | -74.12 | -64.02 | -50.39 | -45.34 | -33.77 | |
| Shares Outstanding (Basic) | 93 | 74 | 54 | 28 | 19 | |
| Shares Outstanding (Diluted) | 93 | 74 | 54 | 28 | 19 | |
| Shares Change (YoY) | 25.21% | 38.53% | 88.63% | 48.94% | 108.30% | |
| EPS (Basic) | -0.80 | -0.86 | -0.94 | -1.60 | -1.77 | |
| EPS (Diluted) | -0.80 | -0.86 | -0.94 | -1.60 | -1.77 | |
| Free Cash Flow | -62.06 | -69.18 | -37.44 | -43.53 | -33.27 | |
| Free Cash Flow Per Share | -0.67 | -0.93 | -0.70 | -1.53 | -1.74 | |
| Operating Margin | -40856.32% | -28899.57% | -15557.79% | -446.79% | - | |
| Profit Margin | -39009.47% | -27243.83% | -14274.50% | -436.53% | - | |
| Free Cash Flow Margin | -32664.74% | -29440.00% | -10605.10% | -419.09% | - | |
| EBITDA | -76.96 | -67.21 | -54.33 | -46.17 | -33.54 | |
| D&A For EBITDA | 0.66 | 0.71 | 0.59 | 0.23 | 0.48 | |
| EBIT | -77.63 | -67.91 | -54.92 | -46.4 | -34.02 | |
| Revenue as Reported | 0.19 | 0.24 | 0.35 | 10.39 | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.